111 related articles for article (PubMed ID: 2108046)
21. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
Boraschi D; Meltzer MS
J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720
[TBL] [Abstract][Full Text] [Related]
22. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.
Taramelli D; Holden HT; Varesio L
J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155
[TBL] [Abstract][Full Text] [Related]
23. Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice: major NKT cell recruitment and increased cytotoxicity.
Ananias RZ; Rodrigues EG; Braga EG; Squaiella CC; Mussalem JS; Longhini AL; Travassos LR; Longo-Maugéri IM
Scand J Immunol; 2007 Jun; 65(6):538-48. PubMed ID: 17523946
[TBL] [Abstract][Full Text] [Related]
24. Functions of multinucleated giant cells formed by fusing rat alveolar macrophages with lymphokines containing macrophage fusion factor.
Sone S
Lymphokine Res; 1984; 3(4):163-73. PubMed ID: 6333567
[TBL] [Abstract][Full Text] [Related]
25. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2).
Hamann U; Krammer PH
Eur J Immunol; 1985 Jan; 15(1):18-24. PubMed ID: 3917924
[TBL] [Abstract][Full Text] [Related]
26. Macrophage response to bacteria and bacterial products: modulation of Fc gamma receptors and secretory and cellular activities.
Keller R; Keist R; Joller PW
Immunology; 1994 Jan; 81(1):161-6. PubMed ID: 8132214
[TBL] [Abstract][Full Text] [Related]
27. Transient expression of the IL-2 receptor alpha-chain in IL-6-induced myeloid cells is regulated by autocrine production of prostaglandin E2.
Ruhl S; Begley CG; Bickel M; Pluznik DH
Exp Hematol; 1992 Jun; 20(5):619-25. PubMed ID: 1587308
[TBL] [Abstract][Full Text] [Related]
28. Activation of tumoricidal properties in macrophages by lymphokines encapsulated in liposomes.
Fidler IJ; Fogler WE
Lymphokine Res; 1982; 1(3):73-7. PubMed ID: 6765335
[No Abstract] [Full Text] [Related]
29. Dissociation between macrophage tumoricidal capacity and suppressive activity: analysis with macrophage-defective mouse strains.
Boraschi D; Pasqualetto E; Ghezzi P; Salmona M; Bartalini M; Barbarulli G; Censini S; Soldateschi D; Tagliabue A
J Immunol; 1983 Oct; 131(4):1707-13. PubMed ID: 6311895
[TBL] [Abstract][Full Text] [Related]
30. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
Poste G; Kirsh R; Fogler WE; Fidler IJ
Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
[TBL] [Abstract][Full Text] [Related]
31. Docosahexaenoic acid, a constituent of rodent fetal serum and fish oil diets, inhibits acquisition of macrophage tumoricidal function.
Dustin LB; Shea CM; Soberman RJ; Lu CY
J Immunol; 1990 Jun; 144(12):4888-97. PubMed ID: 2141046
[TBL] [Abstract][Full Text] [Related]
32. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
Taramelli D; Varesio L
J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
[TBL] [Abstract][Full Text] [Related]
33. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
34. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
Ruco LP; Meltzer MS
J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow macrophages induced to antigen presentation by lymphokines interact selectively with distinct T cells.
Fischer HG; Reske-Kunz AB; Spaeth E; Rüde E
Eur J Immunol; 1985 Sep; 15(9):957-60. PubMed ID: 3876225
[TBL] [Abstract][Full Text] [Related]
36. Induction, maintenance, and reinduction of tumoricidal activity in bone-marrow-derived mononuclear phagocytes by macrophage-activating lymphokines.
Keller R; Keist R
Cell Immunol; 1986 Sep; 101(2):659-66. PubMed ID: 3530506
[TBL] [Abstract][Full Text] [Related]
37. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
Boraschi D; Meltzer MS
J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway.
Paulnock DM; Lambert LE
J Immunol; 1990 Jan; 144(2):765-73. PubMed ID: 2104906
[TBL] [Abstract][Full Text] [Related]
39. Immunoregulation by macrophages II. Separation of mouse peritoneal macrophages having tumoricidal and bactericidal activities and those secreting PGE and interleukin I.
Hopper KE; Cahill JM
J Reticuloendothel Soc; 1983 Jun; 33(6):443-56. PubMed ID: 6602218
[TBL] [Abstract][Full Text] [Related]
40. Macrophage tumoricidal activity induced by human C-reactive protein.
Zahedi K; Mortensen RF
Cancer Res; 1986 Oct; 46(10):5077-83. PubMed ID: 3489521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
